Thomas J. Stopka

Professor @TuftsPH @TuftsMedSchool; epidemiologist; SUD, infectious disease, opioid overdose, spatial epidemiology; in search of equity.

[Thomas J. Stopka @StopkaThomas]

Hot off the presses is our research letter focused on the steep increase in uptake of extended-release (i.e., injectable) buprenorphine to treat people with opioid use disorder. We noted a concurrent decrease in non-extended release buprenorphine treatment between 2018 and 2023.

[JAMA Network Open @JAMANetworkOpen]

From 2018 to 2023, the use of extended-release buprenorphine increased among people with opioid use disorder in Massachusetts, while the use of non-extended-release buprenorphine decreased. https://t.co/gMP1H8Q8PK @StopkaThomas

[Zoe Weinstein MD, MS @ZoeWeinstein]

As the wife of 🇺🇦 refugee, an addiction doc and a huge fan of Claire! I’m so excited to buy alot of these 👕. ❤️🌻

[Sarah Axelrath MD @DrSarahAxelrath]

I’m an addiction specialist and I drink alcohol. I fully support adding the cancer warning label to retail alcohol products. Reducing harm always starts with understanding and acknowledging risk.

[Thomas J. Stopka @StopkaThomas]

Attending Dr. Chandni Joshi’s @Cjoshi01 outstanding talk at @APHA on her cluster analyses focused on hypertension and social vulnerability across Virginia, helping to target local responses! @virginiapublichealth @TuftsMedSchool @TuftsPH

[Thomas J. Stopka @StopkaThomas]

Great to collaborate with @suzanmwalters and our @ruralopioids initiative team on this work with support from @NIDAnews @samhsagov and the Appalachian Regional Commission.

[suzan walters @suzanmwalters]

🚨 New Article 🚨
Our latest research (written w/ @highway_dave, @judith_feinberg, @StopkaThomas, + others) explores harm reduction strategies used by rural people who use drugs to avoid unintentional fentanyl exposure.
#HarmReduction #Fentanyl
https://t.co/c8IfeILvHY

[Paul Christine @pauljchristine]

🚨 We have new work out in @JAMANetworkOpen estimating the effects of relaxing X-waiver training requirements on buprenorphine treatment for opioid use disorder

https://t.co/2u9qoETF4t

1/n

[Stephen Murray, MPH, NRP @stephenHRNRP]

One step closer in Massachusetts…

[Thomas J. Stopka @StopkaThomas]

@KevinYXu @NIDAnews @ebonycartermd @LarochelleMarc @HendreeJ Congrats, Kevin! Looking forward to collaborating!

[Thomas J. Stopka @StopkaThomas]

@Pranay_md @BenjaminLinas Yes, I also jump directly to the Orchid option!

[Thomas J. Stopka @StopkaThomas]

Fantastic to have @_alexbcollins joining the Jumbo community at Tufts!

[Thomas J. Stopka @StopkaThomas]

@_alexbcollins @TuftsUniversity Congrats, Alex! Awesome to have you joining the Jumbo community at Tufts!

[suzan walters @suzanmwalters]

Love this! Amazing work by the whole team and a special shout out to my fabulous K01 mentors @RNBluthenthal and jimi huh

[Karen Freund MD @KarenFreundMD]

Great discussion with @MPOHealthLit @Dmozaffarian @TGandhi_Safety Emily Young, & Frank Osborne on system innovations to achieve #healthjustice.
@hboucher3 @sucharitakher @TuftsMedicalCtr @TuftsMedicine @tuftsctsi @StopkaThomas

[Thomas J. Stopka @StopkaThomas]

@coreysdavis Troubling times. Idaho harm reduction teams were doing fantastic work. Saddened by thoughts about changes in CA as well.

[Thomas J. Stopka @StopkaThomas]

@aaronbflores @SPARC_ASU Thanks, Aaron. Great to meet you and learn about your impressive work!

[Thomas J. Stopka @StopkaThomas]

@_eromo @bmc_FamilyMed Congrats, Eric! Great to have you nearby!

[Ricky N. Bluthenthal @RNBluthenthal]

The backlash against #harmreduction continues. New reporting on what is going on in California in the @latimes by @AlpertReyes with quotes from @barrotlambdin Peter Davidson & @RNBluthenthal
https://t.co/byN0kzhWIO

[Thomas J. Stopka @StopkaThomas]

@WenhuiFeng @SeanBCash @AMJPublicHealth @elinatpage Great work @WenhuiFeng !

[Thomas J. Stopka @StopkaThomas]

Interesting new @TuftsUniversity @TuftsMedSchool study focused on the influence of the gut and microbiome on alcohol use disorder risk. Great work by Andrew Day @TuftsGSBS

[Thomas J. Stopka @StopkaThomas]

We highlight, for instance, differences in rates among non-Hispanic and Hispanic AIAN communities and distinct age strata.

Great to also collaborate with @LarochelleMarc @danabernson @jackcordes94 @BRichard6132359 @wenjunli1056072 & others @UTHealthHouston @TuftsPH @UMassLowell

[Thomas J. Stopka @StopkaThomas]

During recent years, opioid-related overdose rates have increased precipitously within the American Indian and Alaska Native (@AIAN) population, with unique subgroup differences. /1

Trends in Fatal Opioid-Related Overdose in American Indian and Alaska ... https://t.co/AW5ypRvA0z

[Thomas J. Stopka @StopkaThomas]

Along with @cici_mydogisQQ, and our @NIDAnews funded Predict to Prevent (P2P) team, we present findings on some of the latest trends and inflection points in overdose rates within the AIAN community, as well as distinct subpopulations. /2